Answer
Yes, Zilbrysq 23 mg pre-filled syringes may be self-administered subcutaneously after proper training, following the package leaflet’s instructions for use, under the guidance and supervision of healthcare professionals experienced in managing neuromuscular disorders.
Sources for this answer
- Zilbrysq 23 mg solution for injection in pre filled syringeUCB Pharma Limited · emc · SmPC §4.2 Posology and method of administration · Version 4Document updated
Sources checked